-+ 0.00%
-+ 0.00%
-+ 0.00%

ROCHE RECEIVES FDA APPROVAL FOR COMPANION DIAGNOSTIC TESTS TO IDENTIFY PATIENTS WITH HER2-POSITIVE METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA ELIGIBLE FOR ZIIHERA

Reuters·08/26/2026 18:52:37

Please log in to view news